Clinical Trial Update: Abatacept as GVHD Prophylaxis Phase 2 [Phase 2]

View source ↗

Summary

Phase 2 study evaluating abatacept as prophylaxis for graft-versus-host disease showed results for preventing GVHD in transplant patients; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Graft-versus-host Disease

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Graft vs Host Disease, Malignancy | Phase 2 | Status: COMPLETED | Results posted: 2020-06-17